← Leaderboards
Frank C Gibson
Boston Medical Center
$8,525,793
Attributed
$12,178,740
Total exposure
9
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,178,740 · 9
By mechanism
R01$8,795,693 · 4
P01$1,240,431 · 1
R56$1,109,390 · 1
R21$943,250 · 2
F32$89,976 · 1
Top collaborators
- Mary Ellen Davey5 shared
- Jorge Frias-Lopez5 shared
- Andrew J Henderson2 shared
Most similar at Boston Medical Center
Same institution · by research overlap
- Robin R Ingalls$10,629,252
- Douglas T. Golenbock$31,091,869
Others in their field
Top investigators on “Inflammation”
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$89,523,713
- David Heimbrook · Leidos Biomedical Research, Inc.$85,243,263
- Randall J Bateman · Washington University$64,707,456
- Peter Scott Heeger · Case Western Reserve University$56,547,884
Research focus
InflammationInfectionMacrophagePorphyromonas GingivalisPeriodontal DiseasesOralImmune ResponseCytokinePlayBone LossSignal TransductionCellsIn VitroInflammatory ResponseIn VivoResponseInflammatoryPathogenGenesChronicProductionImmuneProgramsOral Cavity
Grant awards (34)
A novel mechanism of virulence control in Porphyromonas gingivalis$644,123
R01 · FY2025 · DE
Microbial sphingolipids and suppression of host inflammation in periodontal disease$562,007
R01 · FY2025 · DE · contact PI
A novel mechanism of virulence control in Porphyromonas gingivalis$645,439
R01 · FY2024 · DE
Microbial sphingolipids and suppression of host inflammation in periodontal disease$564,114
R01 · FY2024 · DE · contact PI
A novel mechanism of virulence control in Porphyromonas gingivalis$679,618
R01 · FY2023 · DE
Microbial sphingolipids and suppression of host inflammation in periodontal disease$581,566
R01 · FY2023 · DE · contact PI
A novel mechanism of virulence control in Porphyromonas gingivalis$666,510
R01 · FY2022 · DE
Microbial sphingolipids and suppression of host inflammation in periodontal disease$574,891
R01 · FY2022 · DE · contact PI
A novel mechanism of virulence control in Porphyromonas gingivalis$692,868
R01 · FY2021 · DE
Microbial sphingolipids and suppression of host inflammation in periodontal disease$585,369
R01 · FY2021 · DE · contact PI
PPARs and periodontal disease$172,802
R21 · FY2016 · DE · contact PI
PPARs and periodontal disease$44,698
R21 · FY2016 · DE · contact PI
PPARs and periodontal disease$261,000
R21 · FY2015 · DE · contact PI
Oral Macrophage Function in the Context of Periodontal Disease and HIV Infection$621,354
R56 · FY2014 · DE
Innate Immunity, Lipid Signaling, and Chronic Infection$213,219
P01 · FY2014 · AI · contact PI
Oral Macrophage Function in the Context of Periodontal Disease and HIV Infection$488,036
R56 · FY2013 · DE
Innate Immunity, Lipid Signaling, and Chronic Infection$228,737
P01 · FY2013 · AI · contact PI
Innate Immunity, Lipid Signaling, and Chronic Infection$293,895
P01 · FY2012 · AI · contact PI
Interferon Regulatory Factors and Periodontal Disease$211,250
R21 · FY2012 · DE · contact PI
Interferon Regulatory Factors and Periodontal Disease$253,500
R21 · FY2011 · DE · contact PI
Innate Immunity, Lipid Signaling, and Chronic Infection$247,007
P01 · FY2011 · AI · contact PI
IInfection-Elicited Oral Bone Loss: TLR2, Ontogency, and Porphromonas Gingivalis$315,273
R01 · FY2010 · DE · contact PI
Innate Immunity, Lipid Signaling, and Chronic Infection$257,573
P01 · FY2010 · AI · contact PI
IInfection-Elicited Oral Bone Loss: TLR2, Ontogency, and Porphromonas Gingivalis$59,086
R01 · FY2010 · DE · contact PI
IInfection-Elicited Oral Bone Loss: TLR2, Ontogency, and Porphromonas Gingivalis$318,458
R01 · FY2009 · DE · contact PI
IInfection-Elicited Oral Bone Loss: TLR2, Ontogency, and Porphromonas Gingivalis$318,458
R01 · FY2008 · DE · contact PI
IInfection-Elicited Oral Bone Loss: TLR2, Ontogency, and Porphromonas Gingivalis$318,103
R01 · FY2007 · DE · contact PI
P. gingivalis Capsule in Cell Inflammation$228,985
R01 · FY2007 · DE · contact PI
The Role of p. gingivalis Capsule in Cell Inflammation$235,825
R01 · FY2006 · DE · contact PI
The Role of p. gingivalis Capsule in Cell Inflammation$241,500
R01 · FY2005 · DE
The Role of p. gingivalis Capsule in Cell Inflammation$281,750
R01 · FY2004 · DE
P. gingivalis Capsule in Cell Inflammation$281,750
R01 · FY2003 · DE
ORAL IMMUNIZATION WITH GINGIPAIN DELIVERED BY SALMONELLA$47,348
F32 · FY2001 · DE
ORAL IMMUNIZATION WITH GINGIPAIN DELIVERED BY SALMONELLA$42,628
F32 · FY2000 · DE